The stock of Amryt Pharma PLC (LON:AMYT) gapped down by GBX 0.1 today and has GBX 12.47 target or 14.00% below today’s GBX 14.50 share price. The 8 months technical chart setup indicates high risk for the GBX 29.58 million company. The gap down was reported on Nov, 18 by Barchart.com. If the GBX 12.47 price target is reached, the company will be worth GBX 4.14 million less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. The stock increased 1.75% or GBX 0.25 on November 18, hitting GBX 14.5. About 118,685 shares traded hands. Amryt Pharma PLC (LON:AMYT) has declined 32.94% since April 20, 2016 and is downtrending. It has underperformed by 37.37% the S&P500.
Amryt Pharma plc, formerly Fastnet Equity plc, is a United Kingdom specialty pharmaceutical company. The company has a market cap of 29.58 million GBP. The Firm focuses on developing and delivering treatments for patients with rare and orphan diseases. It currently has negative earnings. The Company’s products include Episalvan and Imlan.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.